Piangkwan Sa‐nguanmoo

SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats

Piangkwan Sa‐nguanmoo, Pongpan Tanajak, Sasiwan Kerdphoo et al. · Toxicology and Applied Pharmacology · 2017 · 275 citations

Life Sciences, Endocrinology, Neuroscience +14

FGF21 improves cognition by restored synaptic plasticity, dendritic spine density, brain mitochondrial function and cell apoptosis in obese-insulin resistant male rats

Piangkwan Sa‐nguanmoo, Pongpan Tanajak, Sasiwan Kerdphoo et al. · Hormones and Behavior · 2016 · 120 citations

Life Sciences, Neurobiology, Neuroscience +17

Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury

Pongpan Tanajak, Piangkwan Sa‐nguanmoo, Sivaporn Sivasinprasasn et al. · Journal of Endocrinology · 2017 · 120 citations · Full text

Medicine, Cardiology, Pharmacology +17

Obesity accelerates cognitive decline by aggravating mitochondrial dysfunction, insulin resistance and synaptic dysfunction under estrogen-deprived conditions

Wasana Pratchayasakul, Piangkwan Sa‐nguanmoo, Sivaporn Sivasinprasasn et al. · Hormones and Behavior · 2015 · 95 citations

Life Sciences, Neurobiology, Neuroscience +14

FGF21 and DPP-4 inhibitor equally prevents cognitive decline in obese rats

Piangkwan Sa‐nguanmoo, Pongpan Tanajak, Sasiwan Kerdphoo et al. · Biomedicine & Pharmacotherapy · 2017 · 52 citations

Medicine, Endocrinology, Neuroscience +13